The company announced the 50 per cent acquisition of Mumbai-based Sterling Biotech Ltd. Zydus will be taking over Sterling Biotech's API or Active Pharmaceutical Ingredients Business. Zydus Makes ...

Additional Sessions Judge Sidharth Sharma extended the custody of Rajbhushan Omprakash Dixit, a director of Sterling Biotech, after special public prosecutor Nitesh Rana, appearing for the ED ...

In August this year when Zydus acquired a 50 per cent stake in Sterling Biotech Ltd (SBL), the company negotiated for the right to acquire the 'Target Business' of SBL at a pre-defined value.

Michael Gilman, biotech entrepreneur: I am — as a parent and grandparent, rather than a life science executive — considerably ...

Sterling Bay is looking to offload a biotech property on Chicago’s North Side, as its life sciences real estate holdings and its Lincoln Yards project face setbacks. The Chicago-based firm ...

SyVento says bringing the FlexFactory to Poland makes new therapies available to patients in an efficient and high-quality way.

Allison DeAngelis, who covers biotech startups and venture capital, is also the author of STAT’s annual report “Ranking Biotech’s Top Venture Capital Firms.” Biotech investors have been ...

Lincoln Yards developer Sterling Bay plans to sell the biotech center near the North Side development as it faces challenges in the biosciences sector and its own plans for the area. The Lincoln ...

Hello! Hope you had a restful and reflective Indigenous Peoples’ Day. Today, we talk about how the autoimmune disease space is hotter than ever, see more gene therapy contraction, and the CEO of ...

A great performance over the last 12 months has pushed our writer to buy more of a very exciting investment trust for his Stocks and Shares ISA. Paul Summers explains why.

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

SOMERSET, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Alan Bash as the ...